2,226 results on '"Bachert, Claus"'
Search Results
2. Treatment of Nasal Polyposis with Biologics
3. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
4. Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases
5. Respiratory eukaryotic virome expansion and bacteriophage deficiency characterize childhood asthma
6. Olfaction in nasal polyp patients after Reboot surgery: an endotype-based prospective study
7. MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps
8. Human angiotensin-converting enzyme 2–specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants
9. Factors for predicting the outcome of surgery for non-eosinophilic chronic rhinosinusitis with nasal polyps
10. Integrated Care Pathways Integrated care pathways
11. Biologics Biologics in Chronic Rhinosinusitis with Nasal Polyps Chronic Rhinosinusitis with Nasal polyps
12. Reboot Surgery Reboot Surgery
13. Type 2 Immune Reactions Type 2 immune reactions and Consequences
14. The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
15. Patients With Asthma Only Sensitized to Staphylococcus aureus Enterotoxins Have More Exacerbations, Airflow Limitation, and Higher Levels of Sputum IL-5 and IgE
16. Eosinophils and tissue remodeling: Relevance to airway disease
17. The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
18. A novel inflammatory endotype diagnostic model based on cytokines in chronic rhinosinusitis with nasal polyps
19. Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics
20. Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?
21. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
22. Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
23. Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo‐controlled OSTRO trial
24. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
25. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases
26. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
27. DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
28. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
29. The Development of the Mucosal Concept in Chronic Rhinosinusitis and Its Clinical Implications
30. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors
31. Unmet Needs
32. Impact of Endotyping Endotyping on the Indication for Surgery
33. Introduction
34. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
35. Type 2 Immune Reactions and Consequences
36. Integrated Care Pathways
37. Biologics in Chronic Rhinosinusitis with Nasal Polyps
38. Impact of Endotyping on the Indication for Surgery
39. Reboot Surgery
40. Endoskopisches Scoring von Nasenpolypen
41. Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA
42. Associations of tenascin C with Th2 response, edema degree, and disease severity in patients with chronic rhinosinusitis with nasal polyps
43. Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial
44. Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
45. Regulated on Activation, Normal T cell Expressed and Secreted (RANTES) drives the resolution of allergic asthma
46. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
47. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
48. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
49. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective
50. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.